SLC6A3 and Parkinson disease: Using such radiotracers, studies have shown lower striatal DAT binding, indicative of more dopamine denervation (Scherfler et al., 2007), in PD patients with cognitive impairments compared with those without (Chung et al., 2018; Ekman et al., 2012; Schrag et al., 2017).